The American Academy of Dental Sleep Medicine (AADSM) announced that 2,500 dentists across the country have achieved AADSM Qualified Dentist status, strengthening patient access to oral appliance therapy (OAT) for obstructive sleep apnea (OSA). OAT offers a comfortable, clinically-proven treatment option for snoring and OSA. The therapy uses a custom-fit oral […]
Tag: ORAL APPLIANCE THERAPY (OAT)
ProSomnus Prevails in Intellectual Property Lawsuit
ProSomnus Sleep Technologies (“ProSomnus”) has announced a significant victory in its intellectual property enforcement action, reinforcing the Company’s commitment to protecting the innovations, technologies, and proprietary assets that support advances in sleep medicine. The United States District Court for the Southern District of Florida adopted in full the Magistrate Judge’s Report […]
TAP Sleep Care Combination Therapy Delivers 95% AHI Reduction in Severe CPAP-Resistant OSA
TAP Sleep Care highlighted clinical evidence on Combination Therapy for CPAP-Resistant Obstructive Sleep Apnea from Martin A. Denbar, DDS, DABDSM, Diplomate of the American Board of Dental Sleep Medicine and Adjunct Assistant Professor in the Department of Internal Medicine at Texas A&M School of Medicine (Texas Dental Sleep Services). The […]
Great Lakes Introduces Unique Custom MARPE Appliance
Great Lakes Custom MARPE (Miniscrew-Assisted Rapid Palatal Expander) is customizable to meet the patient’s unique needs. The number and location of mini-screws required to achieve the desired expansion are specified by the doctor. Individualized appliance design and strategic mini-implant placement contribute to effective treatment. Great Lakes skilled technicians will provide […]
ProSomnus and MonitAir Collaborate to Enhance Connected Care for OSA
ProSomnus Sleep Technologies (“ProSomnus”), pioneer of Smart Sleep Medicine™, and MonitAir, LLC (“MonitAir”), the premier digital health and tele-monitoring platform for sleep medicine announced a collaboration to support connected, longitudinal and personalized care for patients with obstructive sleep apnea (OSA). Through this collaboration, healthcare providers who prescribe a ProSomnus RPMO₂ […]
Elevating Dental Sleep
Over the past 15 years, I have watched sleep medicine evolve through a number of transformative cycles—from lab-dominant diagnostics to home sleep testing (HST), from regional practices to national telemedicine platforms, and from siloed care to increasingly integrated delivery models. Each wave of change has rewardFed organizations that are willing […]
Weight Loss Medications and Sleep Apnea
The rise in GLP-1 medications for weight loss is undeniable. The amount of money Americans spent on GLP-1 medications skyrocketed more than 500% from 2018 to 2023, according to a 2025 study published in JAMA.1 A recent national health tracking poll of 1,350 U.S. adults reported that one in eight […]
Great Lakes Dental Technologies Partners with TAP Sleep Care for Nylon flexTAP Launch
Great Lakes Dental Technologies announced an exclusive lab partnership with TAP Sleep Care (Airway Management) to launch the groundbreaking Nylon flexTAP®, the world’s first FDA-cleared, single-point midline digitally printed nylon oral appliance for the treatment of snoring and mild to moderate obstructive sleep apnea (OSA). This strategic collaboration brings together […]
ProSomnus Receives FDA Class II Clearance for RPMO₂ OSA Device
ProSomnus Sleep Technologies announced that the U.S. Food and Drug Administration (FDA) has granted Class II 510(k) clearance for its RPMO₂ OSA Device under the product codes DQA, LQZ, LRK, PLC, and OUG (FDA K252765). The RPMO2 OSA Device is the first theragnostic device for sleep medicine, incorporating both precision […]
ProSomnus Secures $38 Million Investment from Catalio Capital to Scale Smart Sleep Medicine
ProSomnus Sleep Technologies announced a strategic investment from Catalio Capital Management, L.P. to accelerate the global expansion of its technology-enabled sleep health platform. Under the agreement, Catalio, a premier healthcare-focused investment firm, has committed up to $38 million to advance development of next-generation remote patient monitoring (RPM) and proprietary sleep […]













